1: Nakajima A, Oda S, Yokoi T. Allopurinol induces innate immune responses through mitogen-activated protein kinase signaling pathways in HL-60 cells. J Appl Toxicol. 2015 Dec 7. doi: 10.1002/jat.3272. [Epub ahead of print] Epub 2015 Jan 7. 3: Larsen KS, Pottegård A, Lindegaard HM, Hallas J. Effect of Allopurinol on Cardiovascular Outcomes in Hyperuricemic patients A Cohort Study. Am J Med. 2015 Nov 14. pii: S0002-9343(15)01047-5. doi: 10.1016/j.amjmed.2015.11.003. [Epub ahead of print] doi: 10.1097/RHU.0000000000000322. 5: Verma AT, Gin K. Allopurinol in Vascular Disease: Is There a New Role for an Old Drug? Can J Cardiol. 2015 Sep 5. pii: S0828-282X(15)01397-5. doi: 10.1016/j.cjca.2015.08.027. [Epub ahead of print] doi: 10.1097/JIM.0000000000000242. doi: 10.2217/pgs.15.125. Epub 2015 Nov 10. doi: 10.1016/j.jval.2015.09.2366. Epub 2015 Oct 20. doi: 10.1016/j.jval.2015.09.2257. Epub 2015 Oct 20. doi: 10.1016/j.jval.2015.09.2251. Epub 2015 Oct 20.